NEET UG 2025: List of medical colleges in Maharashtra to pursue MBBS
NEET UG Maharashtra State MBBS Colleges 2025: Being the third largest state in the country after Rajasthan and Madhya Pradesh, Maharashtra is home to numerous government and private medical colleges. The state has 42 government medical colleges, with two colleges under the central government and the rest under the state government. Here is the list of some of the government medical colleges in Maharashtra:
NEET UG Result 2025 LIVE Updates
All India Institute of Medical Sciences (Nagpur), Armed Forces Medical College (Pune), B. J. Govt. Medical College (Pune), Dr Vaishampayan Memorial Medical College (Solapur), Dr Shankarrao Chavan Govt. Medical College (Nanded), Government Medical Colleges in Alibag, Amravati, Baramati, Akola, Ambernath, Chhatrapati Sambhajinagar, Bhandara, Buldana, Chandrapur, Gadchiroli, Gondia, Hingoli, Jalgaon, among others. Except AIIMS, Nagpur, these state medical colleges come under the Maharashtra University of Health Sciences and are based in Nashik.
Now, let's know which are the private medical colleges in the state: Bharati Vidyapeeth University Medical College (Pune), Dr. D Y Patil Medical College (Kolhapur), Jawaharlal Nehru Medical College (Wardha), Krishna Institute of Medical Sciences (Karad), Maharashtra Institute of Medical Education and Research (Pune), KJ Somaiya Medical College, Symbiosis Medical College for Women (Deemed University), Prakash Institute of Medical Sciences and Research (Sangli) and MGM Medical College and Hospital (Chhatrapati Sambhajinagar), among others.
In the latest NIRF Rankings 2024 released by the Ministry of Education, the following colleges from the state are ranked among the top 50:
—At 11th rank, Dr. D. Y. Patil Vidyapeeth, Pune: The Pune-based college scored 64.10 under the NIRF 2024 medical rankings. The admissions are purely based on the merit list of the NEET UG. Last year, 250 medical seats with 212 for general and 38 for NRI.
The annual fee structure as mentioned in the information brochure for the 2024-25 academic session is Rs 27,00,000 for general and US$ 60,000 for NRI. The annual fees, that is, tuition fees for the MBBS Programme, will be increased by 7% with subsequent instalments, as mentioned in the previous year's brochure.
—At 23rd, Datta Meghe Institute of Higher Education and Research, Wardha: The Wardha-based medical college scored 60.14 under the NIRF 2024 medical rankings. As stated in the information brochure of 2024-25, the fee structure for general students' tuition fee is Rs 20,75,000, while for NRI, it is $ 27,500.
—At 30th, Armed Force Medical College, Pune: The Pune-based medical college ranked 57.68 in the NIRF rankings. In college, graduate students have to compulsorily work as commissioned officers in the Armed Forces Medical Services. A total of 145 medical cadets (115 boys & 30 girls) will be admitted in a year, as mentioned on the official website.
Every MBBS aspirant who wishes to gain admission to a medical college in a state other than their own must check and understand the domicile rules of that state's medical college. In the case of Maharashtra, these are the rules that an aspirant must know:
In Maharashtra, there are five types of domicile rules: Candidature type A, Candidature type B, Candidature type C, Candidature type D, and Candidature type E.
In Candidature type A, an applicant must have completed his or her Class 10th, & 12th from schools in the state. Along with education, the student must have a certificate from the Maharashtra state government affirming that the citizen has lived in the state for 10 years or more. The birth certificate should also mention that the state of birth of the student is Maharashtra.
In Candidature type B, candidates must have completed Class 10 and 12 from Maharashtra-based institutions, and at least one parent must have a Maharashtra domicile certificate.
Type C requires candidates to have passed Class 10 and 12 in Maharashtra, with one parent being a Government of India employee posted in Maharashtra.
Type D includes candidates who completed Class 10 and 12 in Maharashtra schools and have a parent employed by the Maharashtra state government.
Type E applies to candidates who studied in schools along the Maharashtra-Karnataka border, have Marathi as their mother tongue, and possess a domicile or birth certificate from the border area. Each type has specific educational and parental requirements
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Hindustan Times
28 minutes ago
- Hindustan Times
NEET Results 2025 News: List of top medical colleges in India as per NIRF Rankings
National Testing Agency, NTA will release NEET Result 2025 in next two days. As per the official update, the NEET UG results will be announced by June 14, 2025. Once released, candidates who have appeared for National Eligibility cum Entrance Test for undergraduate courses can check the results on official website of NTA NEET at Also read: NEET PG 2025 exam to be held on August 3, check revised schedule here Ahead of the announcement of NEET Result 2025, candidates who have appeared for the exam can have an idea about the top medical colleges in India to apply for. The list shared below is as per NIRF rankings 2024. Rank 1: All India Institute of Medical Sciences (AIIMS) Delhi Rank 2: Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh Rank 3: Christian Medical College, Vellore Rank 4: National Institute of Mental Health and Neuro Sciences, (NIMHANS) Bangalore Rank 5: Jawaharlal Institute of Post Graduate Medical Education and Research (JIPMER), Puducherry Rank 6: Sanjay Gandhi Postgraduate Institute of Medical Sciences (SGPIMS), Lucknow Rank 7: Banaras Hindu University (BHU), Varanasi Rank 8: Amrita Vishwa Vidyapeetham, Coimbatore Rank 9: Kasturba Medical College, Manipal Rank 10: Madras Medical College and Government General Hospital, Chennai Also read: NEET UG Answer Key 2025: Objection window closes today at direct link here The NTA will prepare the Merit List/ All India Rank (AIR) as per Qualifying Criteria and other norms mentioned in the information bulletin. Also read: No fee hike for medical, dental courses in upcoming academic year, assures Karnataka Minister The merit list of the eligible and successful candidates who have opted for 15% of All India quota seats will be prepared by the NTA on the basis of marks obtained in the NEET (UG) - 2025. The list of successful candidates shall be forwarded to the Directorate General of Health Services (Medical Examination Cell), Ministry of Health and Family Welfare, Government of India, and National Commission for Indian System of Medicine (NCISM) and National Commission for Homeopathy (NCH), Ministry of AYUSH, Govt. of India for the purpose of allotment of seats by Online Counselling to 15% All India Quota Seats.
Mint
an hour ago
- Mint
₹1-crore health cover is fast becoming a necessity. But how to buy one?
In 2016, Hyderabad-based Ankur Pathak's mother-in-law was diagnosed with Stage-III ovarian cancer, barely a month or two after undergoing angioplasty. The back-to-back medical emergencies left the family with limited funds to manage the treatment costs. Though she had a reimbursement-based government health cover, the procedural delay and out-of-pocket expenses proved overwhelming. She passed away within three months, unable to continue chemotherapy. The experience made Pathak realize the importance of having a strong insurance cover with adequate immediate support, regardless of employer-provided plans. He opted for ₹50 lakh base coverage, which would increase to ₹1 crore with no-claim bonuses. Also Read: Health insurance vs medical corpus: What should senior citizens prioritize? More Indians are opting for ₹1-crore health covers as medical costs rise. Online insurance platform Policybazaar saw the number of such policies surge to 9,739 in 2024 from 4,427 policies in 2023. 'In 2025, we've already sold 7,521 such policies by May," said Siddharth Singhal, health insurance head at Policybazaar, noting an 85% growth expectation for the year. Why ₹1 crore? Insurance advisors say ₹1 crore may feel excessive today, but five to 10 years down the line, it could be just about right. Medical inflation is pushing costs up fast. Data from the surgery-care company Hexa Health showed that the average severe illness claim in India doubles every 10 years. For example, cancer treatment costs that hovered around ₹2-3 lakh in 2015 now average ₹4-6 lakh, and could touch ₹9 lakh by 2035. Meanwhile, a heart bypass that cost ₹3 lakh a decade ago may cost over ₹6 lakh by 2035. While average treatment costs for severe illnesses provide a baseline, actual expenses often run significantly higher, especially in private hospitals and metro cities, where charges can be 2-3X the national average. Additionally, illnesses rarely occur in isolation; follow-up treatments, diagnostics, and medications add recurring costs over time. One practical way to secure comprehensive coverage is to opt for a ₹1 crore base health insurance policy directly. Take Hyderabad-based Niraj Dugar, a 34-year-old financial planner who holds such a plan. He finds his annual premium of around ₹27,000 manageable, noting that insurers don't charge proportionally more for a significantly higher sum insured. For him, this coverage is essential, not just for today's hospital bills, which can run into lakhs for a single week's stay, but to stay ahead of relentless medical inflation. Before covid-19 hit, Bhumica Aggarwal's father, a businessman from Meerut, invested in a ₹1-crore policy, realizing the premium bump for higher coverage was 'not much'. Five years later, at 67, he happily renews it at ₹87,000 per year. Though claims have been minor, he values it as a critical 'safety net'. Also Read: Why health insurance during and after pregnancy is essential Preeti Zende, a Sebi-registered investment advisor, said a ₹1-crore cover is within reach for anyone with a disposable income of ₹1 lakh or more. To balance affordability, Zende advises gradually increasing coverage. But if one delays it too long, a sudden illness like cancer could prevent them from receiving upgrades. Why start early? 'Even if health issues arise, insurers are more likely to accommodate sum increases for existing policyholders, sometimes with a premium loading or waiting period, than accept fresh applications after diagnosis because getting coverage after it's detected is near impossible," said Zende. One of Zende's clients had opted for a ₹1-crore health cover, combining a base policy with a super top-up. When cancer was diagnosed, the coverage proved critical. Had they waited until after diagnosis, insurers would have outright rejected their application. One of the most popular ways to afford a ₹1-crore health cover is to combine a base policy with a super top-up plan. According to Policybazaar, 80% of its customers opt for a ₹10-lakh base policy paired with a ₹90-lakh super top-up combination compared to other combos. However, Zerodha-backed insurance advisory firm Ditto Insurance warned that while this combo keeps premiums low, super top-ups often come with conditions that can limit how much of the cover one actually uses. 'Super top-ups can have room rent or disease-wise limits. One must understand those conditions and avoid them if possible." If the base and super top-up dates don't align, one may also end up juggling two renewal dates and premium payments. Even so, for those prioritising affordability, this combo remains a go-to. Comprehensive coverage vs super top-ups Ditto Insurance has observed a recent shift: people with higher financial capacity are moving toward comprehensive health plans that automatically increase the sum insured each year, up to a certain cap. These plans often include loyalty bonuses, unlimited restoration benefits, and cover for consumables—benefits that in many cases offer better value than a super top-up. While these policies come at a slightly higher cost, many find them more straightforward and practical. This is what Pathak chose after his mother-in-law passed away. He paid a premium of ₹1.15 lakh for a three-year renewal this year. Starting 2024, insurers in India have come up with health plans that offer 'super bonus" features, typically as add-ons that boost your cover each year, sometimes up to an 'unlimited" sum insured. Priya Deshmukh, head of health products, operations and services at ICICI Lombard, explained that the Elevate plan's 'power booster" add-on 'provides 100% of cumulative bonus annually of the base sum insured every year on year with no cap, thus unlimited sum insured, regardless of whether a claim is made in the preceding year." Aditya Shah, founder of Hercules Insurance Advisors, called these the 'first option" for those targeting high coverage. When bought early, such plans can grow to ₹3-5 crore over the years. He suggested that a ₹1-crore health insurance policy may be unnecessary, due to the availability of newer 2024 plans with features like annual cover increases. Shah described such plans as more 'sustainable" long-term options compared to high-premium ₹1-crore covers, especially as premiums become unaffordable with age. However, Ditto pointed out that super bonus add-ons, especially those with unlimited accumulation, do not have the same level of security as a base plan does when it comes to lifelong renewability and pricing. There is a risk that insurers might increase the price of these add-ons significantly in the future if the claims associated with these benefits become unsustainable. Also Read: Not many claim mental healthcare insurance. Here's why In the case of the super bonus add-ons, especially those with unlimited accumulation, if you opt out of this cover at the time of renewal, all the bonuses accumulated under the power booster will be reduced to zero. What's the cost-effective way? Experts suggested gradually increasing the sum insured year after year. Next best is the popular base ( ₹10L) + super top-up ( ₹90L) combo—affordable but with hidden limits. Comprehensive plans with in-built increasing cover come third—pricier but packed with features. New 'unlimited growth" policies rank fourth—great on paper, but can be expensive in the long run. What's the simplest but most expensive option? Buying a full ₹1-crore base policy outright—smooth claims but heavy premiums. Vedant Vichare is a contributor to Mint.
&w=3840&q=100)
Business Standard
an hour ago
- Business Standard
ICICI commits ₹550 cr for Tata Memorial's cancer care centre in Vizag
ICICI Bank and Tata Memorial Centre launch advanced cancer block treat 3,000 patients annually Chennai ICICI Bank will collaborate with Tata Memorial Centre (TMC) to construct an eight-storied building at the Homi Bhabha Cancer Hospital and Research Centre (HBCHRC) in Visakhapatnam to 'serve' 3,000 patients annually, said the lender on Thursday. The bank has committed more than Rs 550 crore for the building that will spread over 3.9 lakh square feet and have the latest in medical technology. ICICI Foundation Block for Child and Blood Cancer will serve 3,000 patients annually at HBCHRC, which has a capacity of 6,200 patients. Designed as one of the largest specialised cancer facilities in India, the new building will house over 215 beds. It is expected to be completed by 2027, subject to necessary approvals. ICICI Foundation for Inclusive Growth, the CSR arm of ICICI Bank, will oversee its implementation. The foundation stone was unveiled by Pradeep Kumar Sinha, chairman of ICICI Bank. Sandeep Batra, executive director of ICICI Bank, and Sudeep Gupta, director of Tata Memorial Centre in Mumbai, attended the event. 'We are honoured to partner with TMC in a mission towards cancer care, that aligns with our philosophy of strengthening critical health care infrastructure in the country. This project reflects our commitment to enabling accessible and high-quality medical care for individuals in need,' said Sinha., Batra said: 'Two years ago, we announced our partnership with TMC by committing Rs 1,200 crore to set up three new blocks at its centres in Visakhapatnam, Navi Mumbai, and New Chandigarh. Recognising TMC's latest requirements, we are pleased to enhance our commitment to ₹1,800 crore.' Umesh Mahantshetty, director of HBCHRC, said: 'We are grateful to ICICI Foundation for their generous donation, which will significantly contribute to the advancement of cancer treatment and research. The partnership with ICICI Foundation is a testament to the collective efforts of our institutions in providing top-notch care and improving cancer outcomes for patients across the country.' 'At HBCHRC Visakhapatnam currently, we have been registering approximately 200 new paediatric cancer and 350-400 haematolymphoid cancer patients every year in the past three years. With the new block added, we will be able to augment the existing services substantially including expansion of bone marrow transplant programme and also initiate immunotherapy,' said Girish Chinnaswamy, professor and head, paediatric oncology, Tata Memorial Hospital, Mumbai. ICICI Bank's commitment of Rs 550 crore for the Visakhapatnam hospital is part of the expanded contribution of ₹1,800 crore.
